Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    WuXi Biologics (Cayman) I...

    OTC: WXXWY · Real-Time Price · USD
    7.84
    0.16 (2.02%)
    At close: Aug 20, 2025, 12:22 PM

    WuXi Biologics (Cayman) Income Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 18.68B 17.12B 17.03B 16.55B 15.27B 13.09B 10.29B 8.08B
    Cost of Revenue
    		 11.02B 10.5B 10.21B 9.68B 8.54B 7.14B 5.46B 4.03B
    Gross Profit
    		 7.65B 6.62B 6.83B 6.87B 6.72B 5.95B 4.83B 4.05B
    Operating Income
    		 4.97B 3.47B 3.95B 4.17B 4.35B 4.01B 3.17B 2.79B
    Interest Income
    		 350.37M 64.67M 68.64M 25.73M 51.41M 43.08M 18.84M 36.58M
    Pretax Income
    		 4.83B 3.65B 4.17B 4.96B 5.36B 4.87B 3.99B 3.32B
    Net Income
    		 3.36B 2.63B 3.4B 4.15B 4.42B 4.08B 3.39B 2.79B
    Selling & General & Admin
    		 2.15B 2.36B 2.09B 1.96B 1.69B 1.25B 1.13B 952.31M
    Research & Development
    		 766.44M 795.2M 792.58M 759.88M 689.57M 663.58M 507.83M 299.93M
    Other Expenses
    		 -236.54M n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 2.68B 3.15B 2.65B 1.93B 1.42B 1.12B 854.61M 765.14M
    Interest Expense
    		 157.59M n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 473.6M 411.68M 294.01M 201.2M 162.91M 131.39M 124.65M 106.31M
    Cost & Expenses
    		 13.7B 13.65B 12.86B 11.62B 9.96B 8.27B 6.32B 4.79B
    Income Tax Expense
    		 889.03M 640.13M 603.18M 690.07M 807.87M 618M 484.54M 474.11M
    Shares Outstanding (Basic)
    		 2.15B 2.15B 2.24B 2.18B 2.19B 2.19B 2.21B 2.19B
    Shares Outstanding (Diluted)
    		 2.13B 2.13B 2.17B 2.17B 2.18B 2.19B 2.22B 2.2B
    EPS (Basic)
    		 1.56 1.20 1.54 1.90 2.02 1.86 1.54 1.28
    EPS (Diluted)
    		 1.58 1.22 1.56 1.90 2.02 1.86 1.54 1.28
    EBITDA
    		 6.43B 4.74B 4.93B 4.83B 5.07B 4.6B 3.62B 3.16B
    EBIT
    		 4.99B 3.45B 3.93B 4.17B 4.35B 4.01B 3.17B 2.79B
    Depreciation & Amortization
    		 1.44B 1.29B 995.46M 659.82M 718.63M 585.58M 452.24M 367.9M

    Add to Watchlist